BIOMAT Database Logo BIOMAT Database Logo

OKT3 monoclonal antibody reversal of acute renal allograft rejection unresponsive to conventional immunosuppressive treatments. 1986

G Goldstein, and D J Norman, and C F Shield, and H Kreis, and J Burdick, and M W Flye, and E Rivolta, and T Starzl, and A Monaco

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D005334 Fever An abnormal elevation of body temperature, usually as a result of a pathologic process. Pyrexia,Fevers,Pyrexias
D006084 Graft Rejection An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient. Transplant Rejection,Rejection, Transplant,Transplantation Rejection,Graft Rejections,Rejection, Graft,Rejection, Transplantation,Rejections, Graft,Rejections, Transplant,Rejections, Transplantation,Transplant Rejections,Transplantation Rejections
D006085 Graft Survival The survival of a graft in a host, the factors responsible for the survival and the changes occurring within the graft during growth in the host. Graft Survivals,Survival, Graft,Survivals, Graft
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D013601 T-Lymphocytes Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocytes. When exposed to an antigen, they divide rapidly and produce large numbers of new T cells sensitized to that antigen. T Cell,T Lymphocyte,T-Cells,Thymus-Dependent Lymphocytes,Cell, T,Cells, T,Lymphocyte, T,Lymphocyte, Thymus-Dependent,Lymphocytes, T,Lymphocytes, Thymus-Dependent,T Cells,T Lymphocytes,T-Cell,T-Lymphocyte,Thymus Dependent Lymphocytes,Thymus-Dependent Lymphocyte
D016030 Kidney Transplantation The transference of a kidney from one human or animal to another. Grafting, Kidney,Renal Transplantation,Transplantation, Kidney,Transplantation, Renal,Kidney Grafting,Kidney Transplantations,Renal Transplantations,Transplantations, Kidney,Transplantations, Renal

Related Publications

G Goldstein, and D J Norman, and C F Shield, and H Kreis, and J Burdick, and M W Flye, and E Rivolta, and T Starzl, and A Monaco
Orthoclone OKT3 monoclonal antibody reversal of hepatic and cardiac allograft rejection unresponsive to conventional immunosuppressive treatments.
April 1987, Transplantation proceedings,
G Goldstein, and D J Norman, and C F Shield, and H Kreis, and J Burdick, and M W Flye, and E Rivolta, and T Starzl, and A Monaco
Use of Orthoclone OKT3 monoclonal antibody to reverse acute renal allograft rejection unresponsive to treatment with conventional immunosuppressive regimens.
April 1987, Transplantation proceedings,
G Goldstein, and D J Norman, and C F Shield, and H Kreis, and J Burdick, and M W Flye, and E Rivolta, and T Starzl, and A Monaco
Treatment of acute renal allograft rejection with OKT3 monoclonal antibody.
December 1981, Transplantation,
G Goldstein, and D J Norman, and C F Shield, and H Kreis, and J Burdick, and M W Flye, and E Rivolta, and T Starzl, and A Monaco
Monoclonal antilymphocyte antibody (OKT3) treatment of acute renal allograft rejection.
January 1987, Pharmacotherapy,
G Goldstein, and D J Norman, and C F Shield, and H Kreis, and J Burdick, and M W Flye, and E Rivolta, and T Starzl, and A Monaco
Therapeutic use of OKT3 monoclonal antibody for acute renal allograft rejection.
January 1987, Nephron,
G Goldstein, and D J Norman, and C F Shield, and H Kreis, and J Burdick, and M W Flye, and E Rivolta, and T Starzl, and A Monaco
Acute hypertension after renal allograft rejection therapy with OKT3 monoclonal antibody.
January 1991, The Journal of international medical research,
G Goldstein, and D J Norman, and C F Shield, and H Kreis, and J Burdick, and M W Flye, and E Rivolta, and T Starzl, and A Monaco
Monoclonal antibody (OKT3) rescue in refractory acute renal allograft rejection: report of 3 cases.
December 1989, Journal of the Medical Association of Thailand = Chotmaihet thangphaet,
G Goldstein, and D J Norman, and C F Shield, and H Kreis, and J Burdick, and M W Flye, and E Rivolta, and T Starzl, and A Monaco
Successful reversal of hyperacute renal allograft rejection with the anti-CD3 monoclonal OKT3.
November 1992, Transplantation,
G Goldstein, and D J Norman, and C F Shield, and H Kreis, and J Burdick, and M W Flye, and E Rivolta, and T Starzl, and A Monaco
Evolving use of OKT3 monoclonal antibody for treatment of renal allograft rejection.
December 1984, Transplantation,
G Goldstein, and D J Norman, and C F Shield, and H Kreis, and J Burdick, and M W Flye, and E Rivolta, and T Starzl, and A Monaco
OKT3 monoclonal antibody reversal of renal and hepatic rejection in pediatric patients.
December 1987, The Journal of pediatrics,
Copied contents to your clipboard!